Skip to main content

Shanghai Pharmaceuticals Holding

Shanghai Pharmaceuticals Holding Co., Ltd. is a Chinese state-owned pharmaceutical enterprise that researches, manufactures, distributes, and retails prescription drugs and healthcare products across China. The company operates through four primary business segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Other Operations. Its principal revenue drivers consist of wholesale pharmaceutical distribution sales to domestic hospitals, commercial sales of self-manufactured cardiovascular and oncology drugs, and retail pharmacy sales. Shanghai Pharmaceuticals holds a leading position as China's second-largest pharmaceutical distributor and a major drug manufacturer, operating an integrated supply chain reaching all Chinese provinces. The enterprise caters to public hospitals, retail pharmacy networks, medical providers, and patients nationwide. The company focuses on expanding R&D for innovative oncology biologics, broadening pharmaceutical distribution logistics, acquiring international biopharmaceutical assets, and digitizing retail pharmacy operations. Shanghai Pharmaceuticals Holding Co., Ltd. is headquartered in Shanghai, China, and its shares are publicly listed on the Shanghai Stock Exchange and the Hong Kong Stock Exchange.

9 of the funds FundTelligence covers report a position in Shanghai Pharmaceuticals Holding.

Legal name
Shanghai Pharmaceuticals Holding Co Ltd
Sector
Health Care
Country
China
Funds holding it
9

Funds holding Shanghai Pharmaceuticals Holding

Showing the 8 largest of 9 funds holding it.

Loading...